This study can be used as a basis for PRP to be used as an adjuvant therapy for promoting nerve regeneration and for further studies regarding PRP.
Rates of reaction times were slower among individuals who had long COVID compared with healthy counterparts, a researcher showed in a poster presentation at the 2022 American Neurological Association meeting.
Some people who have been infected with the virus that causes COVID-19 can experience long-term effects from their infection, known as post-COVID conditions (PCC) or long COVID.
Results from a 2022 study in Scientific Reports show that hyperbaric oxygen therapy (HBOT), a noninvasive treatment, can produce changes in the brain that improve long COVID symptoms.
A new long-covid study based on the experiences of nearly 100,000 participants provides powerful evidence that many people do not fully recover months after being infected with the coronavirus.
Despite all the buzz about ketamine’s therapeutic potential, people remain confused about how it works and how to find a doctor who prescribes it.
The tone of the conference was one of optimism regarding the safety and efficacy of ketamine and related compounds.
Commonly used in medicine as an anesthetic, ketamine is also increasingly prescribed to relieve depressive symptoms.
Evaluation of the efficacy of adjunctive lidocaine and ketamine infusions for opioid reduction in the treatment of sickle cell disease in patients.
Ketamine can balance certain neurotransmitters, rebuild stronger neural connections and alter the mood processes of the brain.